Exsulin
Burnsville
About Exsulin
Exsulin Corporation, a therapeutic development company, develops and commercializes drugs for the treatment of type 1 and type 2 diabetes. Its products include Exsulin, which uses a synthetic version of naturally-occurring peptide that induces regeneration of normal functioning pancreatic islet cells. The company was incorporated in 2006 and is based in Burnsville, Minnesota.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.4M
- Funding stage: Private Equity
- Last round: Debt Financing (May 2012)
- Website: exsulin.com
- Phone: +1 952-898-5814
Industries & Categories
Biotechnology, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/exsulin-2296827 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.